Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 2102500
Publisher
Wiley
Online
2021-09-02
DOI
10.1002/advs.202102500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- pH and Glutathione Synergistically Triggered Release and Self-Assembly of Au Nanospheres for Tumor Theranostics
- (2020) Lu An et al. ACS Applied Materials & Interfaces
- Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Lisa Zimmer et al. LANCET
- Immune-related adverse events of checkpoint inhibitors
- (2020) Manuel Ramos-Casals et al. Nature Reviews Disease Primers
- Granzyme B PET Imaging of the Innate Immune Response
- (2020) Kathleen M. Capaccione et al. MOLECULES
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
- (2020) Ravit Geva et al. CANCER
- Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma
- (2020) Kenjiro Namikawa et al. JOURNAL OF DERMATOLOGY
- Reinvigorating exhausted CD8 + cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy
- (2020) Md Amir Hossain et al. MEDICINAL RESEARCH REVIEWS
- Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
- (2019) John M. Findlay et al. EUROPEAN RADIOLOGY
- Immunotherapy for small cell lung cancer: mechanisms of resistance
- (2019) Gerhard Hamilton et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer
- (2019) Ryan Zander et al. IMMUNITY
- MOF Nanoparticles with Encapsulated Autophagy Inhibitor in Controlled Drug Delivery System for Antitumor
- (2018) Xuerui Chen et al. ACS Applied Materials & Interfaces
- Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy
- (2018) Qiong Wu et al. BIOMATERIALS
- Chemotherapeutic Drug Based Metal-Organic Particles for Microvesicle-Mediated Deep Penetration and Programmable pH/NIR/Hypoxia Activated Cancer Photochemotherapy
- (2018) Da Zhang et al. Advanced Science
- Antibodies@MOFs: An In Vitro Protective Coating for Preparation and Storage of Biopharmaceuticals
- (2018) Yifan Feng et al. ADVANCED MATERIALS
- The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging
- (2018) Benjamin M. Larimer et al. CLINICAL CANCER RESEARCH
- Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect
- (2018) Yang Du et al. EUROPEAN RADIOLOGY
- Immune Checkpoint Inhibitors: Basics and Challenges
- (2017) Bin Li et al. CURRENT MEDICINAL CHEMISTRY
- Ultrahigh 19F Loaded Cu1.75S Nanoprobes for Simultaneous 19F Magnetic Resonance Imaging and Photothermal Therapy
- (2016) Hongli Chen et al. ACS Nano
- Near-infrared light-induced dissociation of zeolitic imidazole framework-8 (ZIF-8) with encapsulated CuS nanoparticles and their application as a therapeutic nanoplatform
- (2016) Zhifei Wang et al. CHEMICAL COMMUNICATIONS
- Quantitative Imaging of Glutathione in Live Cells Using a Reversible Reaction-Based Ratiometric Fluorescent Probe
- (2015) Xiqian Jiang et al. ACS Chemical Biology
- Segmented Highly Branched Copolymers: Rationally Designed Macromolecules for Improved and Tunable 19F MRI
- (2015) Kewei Wang et al. BIOMACROMOLECULES
- An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
- (2015) R. Tavare et al. CANCER RESEARCH
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Optimized Metal–Organic-Framework Nanospheres for Drug Delivery: Evaluation of Small-Molecule Encapsulation
- (2014) Jia Zhuang et al. ACS Nano
- Multifunctional Core-Shell Silica Nanoparticles for Highly Sensitive19F Magnetic Resonance Imaging
- (2014) Hisashi Matsushita et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- 19F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical Applications
- (2014) Ilaria Tirotta et al. CHEMICAL REVIEWS
- Ki67 is a promising molecular target in the diagnosis of cancer (Review)
- (2014) LIAN TAO LI et al. Molecular Medicine Reports
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Preoperative Staging of Large Primary Breast Cancer With [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Compared With Conventional Imaging Procedures
- (2008) David Fuster et al. JOURNAL OF CLINICAL ONCOLOGY
- Executioner caspase-3 and caspase-7 are functionally distinct proteases
- (2008) J. G. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started